8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Apr 20, 2026 · 2mo ago · Accession 0001193125-26-164040
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kailera Therapeutics, Inc.
- Ticker
- KLRA
- CIK
- 2096997
- Form type
- 8-K
- Filing date
- Apr 20, 2026
- Report date
- Apr 20, 2026
- Document
- d137434d8k.htm
- Size
- 395 KB